2019
DOI: 10.1245/s10434-019-07230-0
|View full text |Cite
|
Sign up to set email alerts
|

Enteral Feeding Access Has an Impact on Outcomes for Patients with Esophageal Cancer Undergoing Esophagectomy: An Analysis of SEER-Medicare

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 33 publications
0
13
0
Order By: Relevance
“…Using the Surveillance Epidemiology and End Results-Medicare (SEER) database, Lorimer et al[39] found that in patients who underwent esophagectomy, mortality was lower and short-term survival was improved at 90 d with an overall shorter length of hospital stay in patients with a j-tube. Enteral feeding via jejunostomy appears to be associated with improved patient outcomes and allows for early establishment of enteral nutrition for eventual transition to an oral diet, which can be managed in an outpatient setting.…”
Section: Methods Of Artificial Feeding After Esophagectomymentioning
confidence: 99%
“…Using the Surveillance Epidemiology and End Results-Medicare (SEER) database, Lorimer et al[39] found that in patients who underwent esophagectomy, mortality was lower and short-term survival was improved at 90 d with an overall shorter length of hospital stay in patients with a j-tube. Enteral feeding via jejunostomy appears to be associated with improved patient outcomes and allows for early establishment of enteral nutrition for eventual transition to an oral diet, which can be managed in an outpatient setting.…”
Section: Methods Of Artificial Feeding After Esophagectomymentioning
confidence: 99%
“…Intraoperative placement of feeding jejunal tube (FJT) offers a route for enteral nutrition (EN) to bridge the very first postoperative period to a safer stage for oral diet. Despite its extensive use and popularity, the risks and benefits of FJT in patients with esophageal cancer (ESCA) remain controversial (7)(8)(9)(10)(11). In prior studies, FJT has been associated with reduced length of hospital stay, and possibly with improved short-term mortality (8,12).…”
Section: Introductionmentioning
confidence: 99%
“…Despite its extensive use and popularity, the risks and benefits of FJT in patients with esophageal cancer (ESCA) remain controversial (7)(8)(9)(10)(11). In prior studies, FJT has been associated with reduced length of hospital stay, and possibly with improved short-term mortality (8,12). In the presence of anastomotic leakage, a lower risk for severe morbidity was also observed in patients with FJT (13).…”
Section: Introductionmentioning
confidence: 99%
“…This mortality benefit has been corroborated by a study performed by Lorimer et al using the Surveillance Epidemiology and End Results (SEER) database, which found that the majority of their patients e all 65 years of age and older e received j-tubes during esophagectomy, and that mortality among those with j-tubes was lower at 30, 60, and 90 days after esophagectomy with a correspondingly lower length of stay. 12 Based on their data, the authors recommended routine j- tube placement during esophagectomy as the standard of care. We can similarly describe that j-tubes are associated with a mortality benefit without an increase in inpatient resource utilization, although a causal effect cannot be assumed; while we may presume that patients with j-tubes were likely to receive some form of supplemental enteral nutrition, we can neither confirm this nor infer the type, duration, or frequency of enteral feeding actually given.…”
Section: Discussionmentioning
confidence: 99%